TABLE 1.
Baseline demography and differences between groups in anthropometric measures, carotid-femoral PWV, and blood pressure, medication, and glucose and lipid metabolism
| ILI | LCD | P | |
|---|---|---|---|
| Age | 45.2 (10.9) | 42.3 (9.6) | 0.045 |
| Male/female | 32/56 | 34/57 | 0.999 |
| Diabetes | 19 (21) | 25 (27) | 0.388 |
| Hypertension | 68 (77) | 59 (65) | 0.072 |
| Ischemic heart disease | 12 (14) | 2 (2) | 0.005 |
| Smokers | 14 (16) | 18 (20) | 0.560 |
| Weight and anthropometric measures | |||
| Weight, kg | 125.2 (20.4) | 137.8 (22.4) | ≤0.001 |
| Body mass index, kg/m2 | 42.5 (5.1) | 45.7 (5.5) | ≤0.001 |
| Waist circumference, cm | 128 (13) | 133 (13) | 0.007 |
| Fat mass, kg | 58.3 (12.4) | 66.8 (12.9) | ≤0.001 |
| Skeletal muscle mass, kg | 37.7 (7.3) | 39.8 (8.0) | 0.078 |
| PWV and blood pressure | |||
| Carotid-femoral pulse wave velocity, m/s | 8.6 (1.8) | 8.7 (1.7) | 0.837 |
| Systolic blood pressure, mm Hg | 146 (17) | 139 (19) | 0.007 |
| Diastolic blood pressure, mm Hg | 80 (11) | 81 (15) | 0.613 |
| Pulse pressure, mm Hg | 66 (16) | 58 (16) | 0.002 |
| Medication | |||
| β-Blocker | 14 (16) | 11 (12) | 0.521 |
| Calcium-channel blocker | 10 (11) | 11 (12) | 0.999 |
| Inhibitors of the RAA system | 34 (39) | 26 (29) | 0.159 |
| Diuretics | 18 (21) | 12 (13) | 0.232 |
| Statins | 19 (22) | 12 (13) | 0.168 |
| Glucose and lipid metabolism | |||
| Insulin, pmol/L | 94.02 (53.2) | 117.6 (100.1) | 0.060 |
| Glucose, mmol/L | 6.0 (2.2) | 6.1 (2.1) | 0.516 |
| HbA1C, % | 6.0 (1.2) | 6.1 (1.2) | 0.789 |
| HOMA-IR | 4.09 (2.76) | 5.65 (5.97) | 0.057 |
| Total cholesterol, mmol/L | 5.1 (1.0) | 4.9 (0.9) | 0.156 |
| LDL cholesterol, mmol/L | 3.1 (1.0) | 3.1 (0.8) | 0.611 |
| HDL cholesterol, mmol/L | 1.2 (0.3) | 1.1 (0.3) | 0.074 |
| Triglycerides, mmol/L | 1.8 (1.2) | 1.6 (0.9) | 0.703 |
Number (%) or mean (SD). Independent samples t-test or Fischer's exact test.